Viewing Study NCT00796159


Ignite Creation Date: 2025-12-24 @ 2:29 PM
Ignite Modification Date: 2026-01-22 @ 9:27 AM
Study NCT ID: NCT00796159
Status: COMPLETED
Last Update Posted: 2009-12-23
First Post: 2008-11-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Efficacy; Tolerability; Safety; Essential Hypertension View